Medicare Enrolled
Dr. Mikhail Kapchits, M.D.
Cardiovascular Disease · Forest Hills, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kapchits from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kapchits?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kapchits
Dr. Mikhail Kapchits is a cardiovascular disease specialist in Forest Hills, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kapchits performed 18,799 Medicare services across 8,031 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kapchits received a total of $14,945 from 74 pharmaceutical and/or device companies across 845 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kapchits is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in NY
$14,945 industry payments
Medicare Practice Summary
Medicare Utilization ↗18,799
Medicare services
Top 1% in NY for cardiovascular disease
8,031
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~940 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
4,360 | $55 | $73 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
1,772 | $42 | $55 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,719 | $13 | $18 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
1,332 | $44 | $57 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
1,314 | $46 | $61 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,269 | $113 | $151 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
930 | $42 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
864 | $75 | $107 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
787 | $36 | $46 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
659 | $152 | $236 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
641 | $90 | $116 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
625 | $182 | $235 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
345 | $8 | $19 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
325 | $57 | $84 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
322 | $418 | $535 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
289 | $153 | $198 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
243 | $36 | $45 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
237 | $7 | $13 |
| Natriuretic peptide level test A blood test that measures the level of natriuretic peptide, a protein produced by the heart and blood vessels. |
224 | $38 | $150 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
92 | $22 | $30 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
91 | $808 | $1,033 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
72 | $71 | $95 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
63 | $116 | $158 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
48 | $40 | $51 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
33 | $46 | $68 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
33 | $52 | $73 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
31 | $83 | $108 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
18 | $13 | $17 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
18 | $1 | $32 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
15 | $19 | $24 |
| New patient office visit, complex (60-74 min) | 14 | $190 | $243 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
14 | $1 | $31 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.9% high complexity
18.3% medium
77.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,945
Total received (2018-2024)
Avg $2,135/year across 7 years
Top 16% in NY for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
74
Companies
845
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,945 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,988
2023
$2,261
2022
$2,175
2021
$2,244
2020
$1,637
2019
$2,203
2018
$2,438
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$305
GlaxoSmithKline, LLC.
$184
AstraZeneca Pharmaceuticals LP
$169
Merck Sharp & Dohme LLC
$161
Janssen Pharmaceuticals, Inc
$158
E.R. Squibb & Sons, L.L.C.
$155
Bayer Healthcare Pharmaceuticals Inc.
$85
SANOFI-AVENTIS U.S. LLC
$70
Kiniksa Pharmaceuticals International, plc
$68
Amgen Inc.
$66
Boehringer Ingelheim Pharmaceuticals, Inc.
$62
Azurity Pharmaceuticals, Inc.
$56
Lexicon Pharmaceuticals, Inc.
$52
Boston Scientific Corporation
$50
Medtronic, Inc.
$37
Acorda Therapeutics, Inc
$36
Vanda Pharmaceuticals Inc.
$31
Supernus Pharmaceuticals, Inc.
$30
Alexion Pharmaceuticals, Inc.
$28
Neurocrine Biosciences, Inc.
$24
Takeda Pharmaceuticals U.S.A., Inc.
$23
UCB, Inc.
$22
Teva Pharmaceuticals USA, Inc.
$19
HEARTFLOW, INC.
$18
Abbott Laboratories
$18
PFIZER INC.
$16
Neurelis, Inc.
$15
ABBVIE INC.
$15
Endo Pharmaceuticals Inc.
$14
Top 3 companies account for 33.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,164
GlaxoSmithKline, LLC.
$2,033
E.R. Squibb & Sons, L.L.C.
$1,242
Janssen Pharmaceuticals, Inc
$1,141
Boehringer Ingelheim Pharmaceuticals, Inc.
$575
SANOFI-AVENTIS U.S. LLC
$540
AstraZeneca Pharmaceuticals LP
$503
Merck Sharp & Dohme LLC
$469
ARBOR PHARMACEUTICALS, INC.
$458
PFIZER INC.
$427
Medtronic, Inc.
$421
Abbott Laboratories
$369
Amarin Pharma Inc.
$279
Amgen Inc.
$274
Lundbeck LLC
$241
Bayer Healthcare Pharmaceuticals Inc.
$240
UCB, Inc.
$216
Lilly USA, LLC
$186
Actelion Pharmaceuticals US, Inc.
$170
Bayer HealthCare Pharmaceuticals Inc.
$153
Takeda Pharmaceuticals U.S.A., Inc.
$146
Allergan Inc.
$138
Arbor Pharmaceuticals, Inc.
$130
Edwards Lifesciences Corporation
$125
Sunovion Pharmaceuticals Inc.
$115
Lexicon Pharmaceuticals, Inc.
$112
Acorda Therapeutics, Inc
$104
SK Life Science, Inc.
$93
Azurity Pharmaceuticals, Inc.
$89
Novo Nordisk Inc
$85
Neurocrine Biosciences, Inc.
$84
Boston Scientific Corporation
$80
Supernus Pharmaceuticals, Inc.
$74
Daiichi Sankyo Inc.
$73
Nestle HealthCare Nutrition Inc.
$71
Kiniksa Pharmaceuticals International, plc
$68
Harmony Biosciences LLC
$64
Vifor Pharma, Inc.
$63
Almatica Pharma LLC
$63
GENZYME CORPORATION
$61
Vanda Pharmaceuticals Inc.
$60
Avanir Pharmaceuticals, Inc.
$58
Horizon Therapeutics plc
$57
Alnylam Pharmaceuticals Inc.
$49
BIOTRONIK INC.
$48
Kowa Pharmaceuticals America, Inc.
$47
Merck Sharp & Dohme Corporation
$45
Amneal Pharmaceuticals LLC
$43
MEDICOMP INC
$39
W. L. Gore & Associates, Inc.
$37
GE Healthcare
$36
AbbVie Inc.
$33
SCPHARMACEUTICALS INC.
$30
AtriCure, Inc.
$29
Alexion Pharmaceuticals, Inc.
$28
AbbVie, Inc.
$25
BOSTON SCIENTIFIC CORPORATION
$24
Astellas Pharma US Inc
$24
Kiniksa Pharmaceuticals, Ltd.
$23
ABIOMED
$22
Biohaven Pharmaceutical Holding Company Ltd.
$22
Allergan, Inc.
$22
AltaThera Pharmaceuticals LLC
$22
IBSA Pharma Inc.
$21
Teva Pharmaceuticals USA, Inc.
$19
HEARTFLOW, INC.
$18
Otsuka America Pharmaceutical, Inc.
$18
LivaNova USA, Inc.
$17
Neurelis, Inc.
$15
ABBVIE INC.
$15
Assertio Therapeutics, Inc.
$15
Endo Pharmaceuticals Inc.
$14
VistaPharm, Inc.
$14
Gilead Sciences, Inc.
$14
Top 3 companies account for 36.4% of all-time payments
Associated products mentioned in payments ›
3F · ACTIVA · AIMOVIG · AIRSUPRA · ANORO · ANORO ELLIPTA · APTIOM · AVALUS · AVEIR · Accent Pacemaker · Adempas · Arcalyst · Assurity Pacemaker · Austedo XR · BELSOMRA · BIOMONITOR · BOTOX THERAPEUTIC · BREO · BREZTRI · BRILINTA · BYSTOLIC · Briviact · CAMBIA · CAMZYOS · CG FUTURE · CHANTIX · CardioMEMS HF System · Confirm Rx · CoreValve Evolut · Corlanor · Creon · DUOPA · EDARBI · ELIQUIS · EMGALITY · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYS · Edarbi · Edarbyclor · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRct · FUROSCIX · GENERAL DBS · GORE CARDIOFORM Septal Occluder · GRALISE · HETLIOZ · HeartMate 3 Left Ventricular Dev · INBRIJA · INGREZZA · INJECTAFER · Impella · Inpefa · JARDIANCE · Kerendia · LEMTRADA · LEQVIO · LEXISCAN · LOKELMA · LOREEV XR · Licart · Livalo · MITRACLIP · MOUNJARO · MULTAQ · Mitra Clip system · MitraClip System · Movantik · NAMZARIC · NASCOBAL · NORTHERA · NUEDEXTA · NURTEC ODT · Neupro · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · Ongentys · Ozempic · PENNSAID · PONVORY · PRADAXA · PRALUENT · Pacemakers · Qelbree · RAYOS · REXULTI · RYTARY · Repatha · Solia · Sotalol Hydrochloride · TELEPATCH CARDIAC MONITOR · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · Thyquidity · UBRELVY · ULTOMIRIS · UPTRAVI · VALTOCO · VERQUVO · VNS - Sentiva · VRAYLAR · VYEPTI · VYNDAQEL · Vascepa · Veltassa · Verquvo · WAKIX · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wakix · Welchol · XARELTO · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
1,792
Per 100K population
76.9
County median income
$84,961
Nearest hospital
JAMAICA HOSPITAL MEDICAL CENTER
1.6 mi
1.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kapchits is a clinical cardiology specialist, with above-average Medicare volume (top 1% in NY), with low-engagement industry engagement in the top 16% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kapchits experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Kapchits performed 4,360 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kapchits receive payments from pharmaceutical companies?
Yes. Dr. Kapchits received a total of $14,945 from 74 companies across 845 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kapchits's costs compare to other cardiologists in Forest Hills?
Dr. Kapchits's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kapchits) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Forest Hills
Browse cardiologists in Forest Hills ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NY
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NY
Which NY cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology